Q3 2024 Holdings
Filed 2024-11-14 | 119 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $17.9M | 1,070,055 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $18.1M | 768,638 | 0.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $18.8M | 912,552 | 0.3% |
| Acelyrin Inc | COM | 00445A100 | $19.7M | 4,001,711 | 0.4% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $19.8M | 1,500,000 | 0.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $22.3M | 379,130 | 0.4% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $22.6M | 10,909,256 | 0.4% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $22.8M | 12,048,773 | 0.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $22.8M | 435,900 | 0.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $22.9M | 2,006,381 | 0.4% |
| Neuropace Inc(NPCE) | COM | 641288105 | $23.7M | 3,406,335 | 0.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $24.3M | 2,002,939 | 0.4% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $25.0M | 4,377,900 | 0.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $25.4M | 708,400 | 0.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $26.1M | 691,114 | 0.5% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $26.2M | 1,449,073 | 0.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $26.8M | 3,573,000 | 0.5% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $27.6M | 6,059,528 | 0.5% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $29.6M | 1,423,470 | 0.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $29.9M | 675,872 | 0.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $34.8M | 302,220 | 0.6% |
| Icon PLC(ICLR) | SHS | G4705A100 | $35.6M | 123,900 | 0.6% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $35.7M | 156,000 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $35.9M | 911,420 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $36.6M | 1,270,400 | 0.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $36.7M | 6,943,654 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $37.1M | 1,925,300 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $40.5M | 766,906 | 0.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $41.1M | 22,362,850 | 0.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $44.2M | 387,000 | 0.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $44.6M | 1,390,631 | 0.8% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $46.2M | 3,305,801 | 0.8% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $46.3M | 679,816 | 0.8% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $47.1M | 1,665,115 | 0.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $47.5M | 45,200 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $48.0M | 1,044,805 | 0.9% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $49.4M | 73,114,592 | 0.9% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $52.2M | 84,400 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $53.7M | 1,050,055 | 1.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $55.2M | 106,200 | 1.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $57.2M | 1,258,566 | 1.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $59.2M | 1,018,734 | 1.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $63.1M | 7,562,971 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $68.8M | 250,300 | 1.3% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $70.2M | 151,000 | 1.3% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $71.1M | 3,027,328 | 1.3% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $74.8M | 575,000 | 1.4% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $78.3M | 5,779,071 | 1.4% |
| Amgen Inc(AMGN) | COM | 031162100 | $81.3M | 252,300 | 1.5% |
| Natera Inc(NTRA) | COM | 632307104 | $87.3M | 687,500 | 1.6% |